Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cance... ( PITTSBURGH June 6 2011 /- Precision...)

HOME >> MEDICINE >> TECHNOLOGY

Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cancer Patients

Date:6/6/2011

PITTSBURGH, June 6, 2011 /PRNewswire/ -- Precision Therapeutics, Inc. demonstrated data supporting the utility of cell line-derived multi-gene predictors in the prediction of preoperative chemotherapy response in early stage breast cancer at the 2011 ASCO Annual Meeting on June 4, 2011 in Chicago, Illinois. The study, titled, Multigene Predictors Developed on Breast Cancer Cell Lines to Predict Patient Chemotherapy Response: A Validation Study on the NSABP B-27 Trial, combined the genomic profiles of cell lines with their in vitro chemoresponse data to identify genes whose expression was associated with drug response. The resulting MGP was used to predict chemotherapy response in patients.

"Clinical interests currently lie in identifying patients most responsive to specific chemotherapy agents to maximize the benefit of treatment and to minimize unnecessary side effects," stated Kui Shen, Ph.D., a bioinformatics scientist and co-author of the study. "By combining ChemoFx® chemosensitivity data from cell lines with their genomic profiles, Precision has developed a procedure to derive gene signatures that may predict a patient's chemotherapy response prior to treatment. This approach is now confirmed using NSABP B-27 clinical data, showing an accuracy of as high as 75%."

Precision continues to seek and develop strategic products that fit within the cancer care continuum, including multi-gene predictors to help with choosing treatments for triple negative women. Precision has completed 12 separate validations including both NSABP and U.S. Oncology trials.

About Precision Therapeutics

Precision Therapeutics, a leading life-science company based in Pittsburgh, Pennsylvania, is dedicated to personalized cancer care. Precision offers a portfolio of products developed to help guide physicians and patients with difficult clinical decisions throughout the cancer care continuum.

SOURCE Precision Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. TechPrecision Corporation Receives $1.6 Million in New Orders from Existing Customers
2. Volcano to Highlight its Precision Guided Therapy Technologies at EuroPCR
3. Robotic Couch Provides Extra Degree of Precision for Patients Undergoing Radiation Therapy for Cancer
4. Boston Scientific Receives FDA Approval of New Clik(TM) Anchor for Precision Plus(TM) Spinal Cord Stimulator System
5. Source Precision Medicine, Inc. d/b/a Source MDx Announces Foundational Patents Will Be Offered for Sale on April 29, 2011
6. Source Precision Medicine, Inc., dba SourceMDx Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of Finn, Warnke & Gayton, LLP
7. Applied Precision Exhibit at the Biophysical Society Annual Meeting Showcases New Microscopy Solutions for Life Science Industries
8. TechPrecision Corporation Receives New $450,000 Medical Purchase Order
9. Applied Precision Scientific Team to Present 3D-SIM Paper at BiOS in San Francisco
10. Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico
11. Exempla Saint Joseph Hospital Commences Treating Cancer Patients Using New TrueBeam™ System for High-Precision Image-Guided Radiotherapy and Radiosurgery

Post Your Comments:

(Date:5/17/2013)... May 17, 2013 Boehringer Ingelheim will contribute ... at the American Thoracic Society International Conference (ATS ... May 17 – 22. Data will ... the treatment of chronic obstructive pulmonary disease (COPD) ... as investigational compounds for asthma, idiopathic pulmonary fibrosis ...

(Date:5/17/2013)... , May 17, 2013 Oramed ... of oral drug delivery systems, announced today that the ... the Company,s Investigational New Drug application(IND) for ORMD-0801, its ... to have the FDA clearance to proceed," stated ... upcoming trial is a major milestone for Oramed and ...

(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 ... ABBV ) announced today an extension of ... Galapagos will fund and complete a Phase 2 program ... progression into Phase 3. Upon successful completion of the ... $50 million. The terms of the collaboration extension are ...

Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7 Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8 Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2 Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5 AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6

[0] Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference [0] Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.[0] AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease

... Inc. (Nasdaq: IPCM ), a leading national hospitalist physician group practice company, announced ... Wednesday, November 11, 2009 at the 2009 Annual Credit Suisse Health Care Conference in ... Event: 2009 Annual Credit ... Date: Wednesday, November ...

... SAN FRANCISCO, Nov. 4 VIA Pharmaceuticals, Inc. (Nasdaq: ... development of compounds for the treatment of cardiovascular and ... Vice President Research & Development will present "VIA-3196, a ... the Abstract Oral Session on Novel Biological Mechanisms of ...

Cached Medicine Technology:IPC The Hospitalist Company, Inc. to Present at the 2009 Annual Credit Suisse Health Care Conference 2 VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 2 VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 3 VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 4

IPC The Hospitalist Company, Inc. to Present at the 2009 Annual Credit Suisse Health Care Conference VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009

(Date:5/20/2013)... May 20, 2013 AURORA, Colo. – ... online accredited university, has developed a Bachelor of ... assess how they feel about continuing their education and ... print out the complimentary worksheet, respond to ten statements ... they rate on a BSN-readiness scale. , New industry ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 Can you tell a ... to tell a joke? , Would you like to be funnier ... sometimes feel like your funny bone is missing? , Can't think ... 2 hours later? , If this sounds like you, don't worry. ... and develop their sense of humor; and even learn to tell ...

(Date:5/20/2013)... 2013 The transvaginal mesh lawyers at ... firm, report that two important bellwether trials are set ... and federal litigations established for C.R. Bard transvaginal ... C.R. Bard bellwether trial will begin in the federal ... Virginia. (In re: C.R. Bard, Inc., Pelvic Repair ...

(Date:5/20/2013)... May 20, 2013 Townsend Security, ... announced that the company’s Alliance Key Manager hardware ... with Key Connection for TrueCrypt for Windows ... strong passwords when using TrueCrypt for data protection. ... offer secure password management for TrueCrypt encryption. Today's ...

(Date:5/20/2013)... May 20, 2013 Gerald Wojtala, executive ... will speak at North Carolina Food Safety and Defense ... Business: The Need for Partnerships – from Farm to ... conference, scheduled for May 22-23 at the Sheraton Imperial ... the food sector have in protecting the food supply. ...

Breaking Medicine News(10 mins):Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 2 Health News:American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness 3 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 2 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 3 Health News:Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke 4 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 2 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 3 Health News:Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials 4 Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 2 Health News:Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords 3 Health News:IFPTI Executive Director to Speak at North Carolina Food Safety and Defense Task Force Annual Conference 2

[0] American Sentinel University Develops New Worksheet to Help Nurses Determine BSN-Readiness [0] Psychologist Steve Wilson Gives A Dozen Tips to Help You Be More Humorous Even if You Can't Tell a Joke [0] Transvaginal Mesh Lawyers at Wright & Schulte LLC Look Ahead to Upcoming Vaginal Mesh Lawsuit Bellwether Trials [0] Alliance Key Manager, Townsend Security’s FIPS 140-2 Compliant Encryption Key Manager Now Includes Support for Managing TrueCrypt Passwords [0] IFPTI Executive Director to Speak at North Carolina Food Safety and Defense Task Force Annual Conference

... (ESMO) just released an enhanced and revised set ... the best quality care to their patients. ... vital, evidence-based information including the incidence of the ... assessment, treatment plans and follow-up. Formerly known ...

... precancers and cervical cancers is over 50 per cent more ... study in Mexico has revealed. Results of the largest ... a Latin American country point to the readiness of HPV ... online today (8 July 2010) in Cancer, Causes and ...

... ... Attract Most Eyeballs in June , ... Vancouver, BC, Canada (PRWEB) -- Suite101.com, a global content site that provides trusted and ... its site in June 2010, providing a window into consumer online reading behavior. In June, ...

... HealthDay Reporter , WEDNESDAY, July 7 (HealthDay News) ... may be able to control it more effectively on ... researchers contend. Through telemonitoring of their blood pressure ... in advance, patients assigned to self-managed care saw greater ...

... ... over the globe with their unbeatable embroidery and screen printing deals. New office space ... ... 2010 -- Uncle Sam can’t hold down this online apparel giant. Times may be ...

... , ... last week, funded by grants from the Mesothelioma Applied Research Foundation and the National ... in treatment and prevention of this aggressive and deadly cancer. , ... (PRWEB) July 8, 2010 -- Last ...

Cached Medicine News:Health News:ESMO publishes updated guidelines on cancer care 2 Health News:ESMO publishes updated guidelines on cancer care 3 Health News:HPV DNA testing over 50 percent more sensitive than cytology testing 2 Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 2 Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 3 Health News:Suite 101.com Provides Insight Into Consumer Reading Behavior Online 4 Health News:Monitoring Blood Pressure at Home May Help Keep It Low 2 Health News:Monitoring Blood Pressure at Home May Help Keep It Low 3 Health News:Clothing4all WOWs Yet Again With Customer Appreciation and Increased Sales 2 Health News:Discovery Opens Door for New Options in Prevention and Treatment of Mesothelioma 2 Health News:Discovery Opens Door for New Options in Prevention and Treatment of Mesothelioma 3

ESMO publishes updated guidelines on cancer care HPV DNA testing over 50 percent more sensitive than cytology testing Suite 101.com Provides Insight Into Consumer Reading Behavior Online Monitoring Blood Pressure at Home May Help Keep It Low Clothing4all WOWs Yet Again With Customer Appreciation and Increased Sales Discovery Opens Door for New Options in Prevention and Treatment of Mesothelioma

... with self-adjusting adaptability to fit almost every ... of angling at the sit of fixation ... permits it to be titled to any ... Intern®, a simple adjustment of the 3/D ...

Stainless steel construction to withstand sterilization modalities (EtO, Steris, and Sterrad)...

Inquire...

ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....

Medicine Products:

3D/SwingerOperating Table Clamp MicroLaparoscopes Ackerman Laparoscopes 10mm ENDOlap™ Millennium Laparoscopes